FDA approves Gilead's Descovy

FDA approved Descovy emtricitabine/tenofovir alafenamide from Gilead Sciences Inc. (NASDAQ:GILD) to treat HIV-1 infection in patients aged 12 and older in combination with other antiretroviral agents. ...